Evaluation of GEPIA2 results from BC patients demonstrated that ZEB2‐AS1 overexpression in BC tissues was remarkably related to a poor OS than ZEB2‐AS1 low expression (HR = 0.61, p = .038; Figure 3). Here, ZEB2 is linked to breast cancer.